My own bio-imprint as asset for competitive advantage

Informazioni relative al progetto

MYBIOASSET

ID dell’accordo di sovvenzione: 711328

DOI

10.3030/711328

Progetto chiuso

Data della firma CE 30 Novembre 2015

Data di avvio 1 Dicembre 2015

Data di completamento 31 Maggio 2016

Finanziato da

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology

Costo totale

€ 71 429,00

Contributo UE

€ 50 000,00

Coordinato da

INBIOLEV SL
Spain

Periodic Reporting for period 1 - MYBIOASSET (My own bio-imprint as asset for competitive advantage)

Periodo di rendicontazione: 2015-12-01 al 2016-05-31

Sintesi del contesto e degli obiettivi generali del progetto

LEV2050 has developed and tested MYBIOASSETS, a method, procedure and technology to genetically select, preserve and reproduce indigenous yeasts, from different strains and genders. With this technology, wineries can create their own, unique wines with special characteristics provided by their own yeasts, selected from their vineyards, and reproduce those special flavours year after year making a difference among their competitors. MYBIOASSETS has been tested in several wineries in Spain with excellent results. The tailored engineered bioreactors designed by LEV2050 will help wineries to reproduce year after year the selected yeasts maintaining the highest level of quality.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

"""The feasibility study has been carried out during 2016 and covers nex sections: MARKET STUDY AND INVOLVEMENT OF KEY STAKEHOLDERS: - Market features
- Value chain
- Market segments
- Opportunity
- Competition
- Regulation
- Commercialisation
- Risks
- Time to market FREEDOM TO OPERATE, VALUE PROPOSITION AND BUSINESS MODEL - Product/service
- Differentiation
- IPR
- Prospective
- Business model COST, REVENUES AND FUNDING SCHEME""
"

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

In comparison to competition products, MYBIOASSETS has a wider potential of differenciation. Instead of use commercial yeasts present in the market, each winery has the opportunity to select those yeasts present in their vineyards that provide wines with the most desirable organoleptic qualities. This differenciation allows wineries to make a difference in the market, improving sales expectations. With the help of tailored bioreactors, yeast cost per campaign will be affordable for wineries, independently from their size.

lev2050-2.png

lev2050-1.png